Navigation Links
Pubertal development may predispose women to pain and other symptoms

Although chronic/recurrent pain is generally considered a problem of adults, rates of some pain conditions - particularly back pain and headache - are substantial in adolescents, ranging from 20-50% of the teenage population.//

Temporomandibular (TMD) pain, abdominal pain, migraine and tension-type headache are more prevalent in adult women than in men.

Female reproductive hormones are known to be associated with increased risk of migraine. Use of hormone replacement therapy in post-menopausal women has also been identified as a risk factor for back pain and TMD pain.

If the presence of reproductive hormones increases the risk of developing pain, pain prevalence should increase as girls pass through puberty.

A recent study, to be published in the journal Pain (available online 5 October 2005), assessed the relationship of back pain, headache, abdominal pain and TMD pain, as well as the presence of multiple pain conditions, to gender, pubertal development and age in a cross sectional, population-based telephone survey of adolescents. The authors examined the association between pubertal development and depressive and somatic symptoms, factors often associated with pain in adults.

Subjects (3101 boys and girls, 11–17 years old) reported on the presence of each pain condition in the prior 3 months and completed scales assessing pubertal development, and depressive and somatic symptoms.

Data were analyzed and prevalence rates were weighted for factors affecting response. Prevalence of back pain, headache and TMD pain increased significantly and stomach pain increased marginally with increasing pubertal development in girls. Rates of somatization, depression and probability of experiencing multiple pains also increased with pubertal development in girls. For boys, prevalence of back and facial pain increased, stomach pain decreased and headache prevalence was virtually unchanged with increasing maturity. For both sexes, pubertal development was a better predictor of pain than was age.

Thus it appears that pain, other somatic symptoms and depression increase systematically with pubertal development in girls. These results confirm that the prevalence of pain conditions in adolescents, particularly adolescent girls, is substantial. In addition, the authors found that physical development as well as gender, is associated with the experience of pain in adolescents. Specifically, in girls, pubertal development was related not only to the probability of experiencing specific pain conditions, but also to the probability of experiencing multiple pain problems. The probability of experiencing significant levels of non-pain physical symptoms, as well as depressive symptoms, also increased with pubertal development in girls.

These findings suggest that the process of pubertal development may initiate biological changes that predispose women, in particular, to experience symptoms, including pain.
'"/>




Related medicine news :

1. Cancer drugs in development nearly doubled since 1995
2. Role of zinc in development
3. Particulate matter affects lung development
4. Fossil teeth and human development
5. High development costs hinder entry of cancer super drugs into the market
6. Fireflies help speed development of new drugs
7. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
8. New fertility drug development techniques by Organon
9. Biosensor chip to help drug development
10. Cells critical for asthma development found
11. ICMR along with other International Research organisation with drug development for Neglected Diseases
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... a new partnership with the Rhode Island Consortium for Autism Research and Treatment ... opportunity for children with autism spectrum disorder (ASD) to see films in an ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... ... February 22, 2017 , ... When ... new healthcare contact center in Georgia, PENETRON Specialty Products (PSP) provided the solution. ... healthcare systems recently invested $51 million to purchase and renovate the 185,000 square-foot ...
(Date:2/22/2017)... Angeles, CA (PRWEB) , ... February 22, 2017 , ... ... detox treatment to the thousands of individuals who have recently fallen victim to America’s ... hospital in Orange County, California, where they are free from the shame, stigma, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... leads to fewer trips the emergency room, fewer hospital admissions, and better blood ... of Managed Care® (AJMC®) finds. The study can be found here . ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017   SeraCare Life ... global in vitro diagnostics manufacturers and clinical laboratories, ... "Catalyzing Implementation of NGS-Based Tests" to be hosted ... 2017 at 11am Eastern Standard Time (US). ... highlight the need for improved performance and global ...
(Date:2/23/2017)... -- ML Capital Group, Inc. (USOTC: MLCG) today announced ... , a Colorado -based cannabis tourism company. ... (USOTC: PURA) to enter Colorado,s $19 billion ... Tours acquisition announced today is intended to accelerate MLCG,s ... ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... a clinical-stage oncology drug development company, announces that ... and Drug Administration (FDA) authorizing the initiation a ... therapeutic treatment for pancreatic cancer. MVT-1075 ( 177 ... radioimmunotherapy (RIT). MabVax plans to initiate the phase ...
Breaking Medicine Technology: